Sol Jeanine J, Knoester Hennie, de Neef Marjorie, Smets Anne M J B, Betlem Aukje, van Ommen C Heleen
*Department of Pediatrics, Groene Hart Hospital, Gouda †Pediatric Intensive Care Unit Departments of ‡Pediatric Radiology ∥Pediatric Hematology, Emma Children's Hospital/AMC, Amsterdam §Intensive Care Unit, Red Cross Hospital, Beverwijk, The Netherlands.
J Pediatr Hematol Oncol. 2015 Aug;37(6):462-7. doi: 10.1097/MPH.0000000000000370.
Prescription of thromboprophylaxis is not a common practice in pediatric intensive care units. Most thrombi are catheter-related and asymptomatic, without causing acute complications. However, chronic complications of these (a)symptomatic catheter-related thrombi, that is, postthrombotic syndrome (PTS) and residual thrombosis have not been studied. To investigate these complications, critically ill children of 1 tertiary center with percutaneous inserted femoral central venous catheters (FCVCs) were prospectively followed. Symptomatic FCVC-thrombosis occurred in 10 of the 134 children (7.5%; 95% confidence interval [CI], 2.4-9.5). Only FCVC-infection appeared to be independently associated (P=0.001) with FCVC-thrombosis. At follow-up 2 of the 5 survivors diagnosed with symptomatic thrombosis developed mild PTS; one of them had an occluded vein on ultrasonography. A survivor without PTS had a partial occluded vein at follow-up. Asymptomatic FCVC-thrombosis occurred in 3 of the 42 children (7.1%; 95% CI, 0.0-16.7) screened by ultrasonography within 72 hours after catheter removal. At follow-up, mild PTS was present in 6 of the 33 (18.2%; 95% CI, 6.1-30.3) screened children. Partial and total vein occlusion was present in 1 (3%) and 4 (12%) children, respectively. In conclusion, children on pediatric intensive care units are at risk for (a)symptomatic FCVC-thrombosis, especially children with FCVC-infection. Chronic complications of FCVC-thrombosis are common. Therefore, thromboprophylaxis guidelines are warranted in pediatric intensive care units to minimize morbidity as a result of FCVC-thrombosis.
在儿科重症监护病房,进行血栓预防用药并非常见做法。大多数血栓与导管相关且无症状,不会引发急性并发症。然而,这些(有)无症状的导管相关血栓的慢性并发症,即血栓后综合征(PTS)和残余血栓形成,尚未得到研究。为了调查这些并发症,对一家三级中心患有经皮插入股静脉中心静脉导管(FCVC)的危重症儿童进行了前瞻性随访。134名儿童中有10名出现有症状的FCVC血栓形成(7.5%;95%置信区间[CI],2.4 - 9.5)。仅FCVC感染似乎与FCVC血栓形成独立相关(P = 0.001)。在随访中,5名被诊断为有症状血栓形成的幸存者中有2名出现轻度PTS;其中1名在超声检查时静脉闭塞。一名没有PTS的幸存者在随访时有部分静脉闭塞。在导管拔除后72小时内接受超声检查的42名儿童中有3名出现无症状的FCVC血栓形成(7.1%;95% CI,0.0 - 16.7)。在随访中,33名接受筛查的儿童中有6名出现轻度PTS(18.2%;95% CI,6.1 - 30.3)。分别有1名(3%)和4名(12%)儿童出现部分和完全静脉闭塞。总之,儿科重症监护病房的儿童有发生(有)无症状FCVC血栓形成的风险,尤其是患有FCVC感染的儿童。FCVC血栓形成的慢性并发症很常见。因此,儿科重症监护病房有必要制定血栓预防指南,以将FCVC血栓形成导致的发病率降至最低。